UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Animal models of l-DOPA-induced dyskinesia: the 6-OHDA-lesioned rat and mouse

Journal of Neural Transmission, 2018-08, Vol.125 (8), p.1137-1144

2018

Volltextzugriff (PDF)

Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism

Brain (London, England : 1878), 2014-07, Vol.137 (Pt 7), p.1998-2014

2014

Volltextzugriff (PDF)

Sigma-1 receptor：a potential new target for Parkinson’s disease

Neural regeneration research, 2014-11, Vol.9 (21), p.1882-1883

Francardo, Veronica

2014

Volltextzugriff (PDF)

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

Neuron (Cambridge, Mass.), 2015-11, Vol.88 (4), p.762-773

2015

Volltextzugriff (PDF)

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease

Neurobiology of disease, 2011-06, Vol.42 (3), p.327-340

2011

Volltextzugriff (PDF)

Dramatic differences in susceptibility to L -DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion

Neurobiology of disease, 2016-10, Vol.94, p.213-225

2016

Volltextzugriff (PDF)

Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia

Proceedings of the National Academy of Sciences - PNAS, 2014-03, Vol.111 (12), p.4578-4583

2014

Volltextzugriff (PDF)

Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current options

Behavioural brain research, 2018-10, Vol.352, p.142-150

Francardo, Veronica

2018

Volltextzugriff (PDF)

Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia

International journal of molecular sciences, 2022-04, Vol.23 (7), p.4062

2022

Volltextzugriff (PDF)

Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa—induced dyskinesia

Proceedings of the National Academy of Sciences - PNAS, 2010-12, Vol.107 (50), p.21824-21829

2010

Volltextzugriff (PDF)

Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia

Brain (London, England : 1878), 2011-08, Vol.134 (8), p.2339-2357

2011

Volltextzugriff (PDF)

Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse

Parkinsonism & related disorders, 2014, Vol.20 (SUPPL.1), p.S20-S22

2014

Volltextzugriff (PDF)

Rodent models of impulsive–compulsive behaviors in Parkinson's disease: How far have we reached?

Neurobiology of disease, 2015-10, Vol.82 (aug 29), p.561-573

2015

Volltextzugriff (PDF)

Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice

Proceedings of the National Academy of Sciences - PNAS, 2016-02, Vol.113 (5), p.1423-1428

2016

Volltextzugriff (PDF)

Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease

Experimental neurology, 2017-12, Vol.298 (Pt B), p.137-147

2017

Volltextzugriff (PDF)

Sigma-1 receptor: a potential new target for Parkinson′s disease?

Neural regeneration research, 2014-11, Vol.9 (21), p.1882-1883

Francardo, Veronica

2014

Volltextzugriff (PDF)

Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease

Neurotherapeutics, 2019-04, Vol.16 (2), p.465-479

2019

Volltextzugriff (PDF)

AM‐301, a barrier‐forming nasal spray, versus saline spray in seasonal allergic rhinitis: A randomized clinical trial

Allergy (Copenhagen), 2024-07, Vol.79 (7), p.1858-1867

2024

Volltextzugriff (PDF)

Increased CSF biomarkers of angiogenesis in Parkinson disease

Neurology, 2015-11, Vol.85 (21), p.1834-1842

2015

Volltextzugriff (PDF)

Animal models of l -DOPA–induced dyskinesia: an update on the current options

Neuroscience, 2012-06, Vol.211, p.13-27

2012

Volltextzugriff (PDF)

Compensatory changes in degenerating spinal motoneurons sustain functional sparing in the SOD1‐G93A mouse model of amyotrophic lateral sclerosis

Journal of comparative neurology (1911), 2020-02, Vol.528 (2), p.231-243

2020

Volltextzugriff (PDF)

Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia

Scientific reports, 2017-11, Vol.7 (1), p.16005-11, Article 16005

2017

Volltextzugriff (PDF)

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

Neuron (Cambridge, Mass.), 2016-06, Vol.90 (5), p.1139-1139

2016

Volltextzugriff (PDF)

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

Neuron (Cambridge, Mass.), 2015-11, Vol.88 (4), p.762-73

2015

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)
Buchkapitel
(2)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Medical And Health Sciences
(21)
Medicin Och Hälsovetenskap
(21)
Neurosciences
(21)
Life Sciences & Biomedicine
(20)
Neurosciences & Neurology
(18)
Animals
(16)
Neurology
(15)
Neurovetenskaper
(14)
Basic Medicine
(12)
Medicinska Och Farmaceutiska Grundvetenskaper
(12)
Parkinson's Disease
(12)
Clinical Medicine
(9)
Disease Models, Animal
(9)
Humans
(9)
Klinisk Medicin
(9)
Mice
(9)
Neurologi
(9)
6-Hydroxydopamine
(7)
Dyskinesia
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Animal models of l-DOPA-induced dyskinesia: the 6-OHDA-lesioned rat and mouse

Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism

Sigma-1 receptor：a potential new target for Parkinson’s disease

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease

Dramatic differences in susceptibility to L -DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion

Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia

Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current options

Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia

Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa—induced dyskinesia

Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia

Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse

Rodent models of impulsive–compulsive behaviors in Parkinson's disease: How far have we reached?

Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice

Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease

Sigma-1 receptor: a potential new target for Parkinson′s disease?

Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease

AM‐301, a barrier‐forming nasal spray, versus saline spray in seasonal allergic rhinitis: A randomized clinical trial

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

Increased CSF biomarkers of angiogenesis in Parkinson disease

Animal models of l -DOPA–induced dyskinesia: an update on the current options

Compensatory changes in degenerating spinal motoneurons sustain functional sparing in the SOD1‐G93A mouse model of amyotrophic lateral sclerosis

Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

Suchergebnisse filtern